Daniel v. Hawkins

CourtSupreme Court of Delaware
DecidedJanuary 6, 2023
Docket184, 2022
StatusPublished

This text of Daniel v. Hawkins (Daniel v. Hawkins) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Daniel v. Hawkins, (Del. 2023).

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

BRADLEY DANIEL, an individual, and § MEDAPPROACH HOLDINGS, INC., a § Delaware corporation, § § No. 184, 2022 Defendants Below, § Appellants, § § Court Below: Court of Chancery v. § of the State of Delaware § SHARON HAWKINS, individually and § derivatively on behalf of § C.A. No. 2021-0453 MEDAPPROACH, L.P., § § Plaintiff Below, § Appellee. §

Submitted: November 2, 2022 Decided: January 6, 2023

Before VALIHURA, VAUGHN, and TRAYNOR, Justices.

Upon appeal from the Court of Chancery. AFFIRMED.

David Teklits, Esquire (argued), Sara Barry, Esquire, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, Delaware; Of Counsel: Jeffrey Alan Simes, Esquire, Goodwin Proctor LLP, New York, New York for Appellants.

Richard I.G. Jones, Esquire (argued), John G. Harris, Esquire, Berger Harris LLP, Wilmington, Delaware for Appellee.

VALIHURA, Justice: Following a trial, on April 4, 2022, the Court of Chancery entered judgment in favor

of appellee Sharon Hawkins (“Mrs. Hawkins” or “Appellee”) on her request for a

declaration that the irrevocable proxy which provides appellant W. Bradley Daniel

(“Daniel”)1 with voting power over all 100 shares of N.D. Management, Inc. (“Danco GP”)

(the “Irrevocable Proxy”), does not bind a subsequent owner of such Danco GP shares.

The Court of Chancery also held that an addendum to the Irrevocable Proxy does not

obligate the current owner of the Danco GP shares, MedApproach, L.P. (the “Partnership”),

to demand that the buyer in a sale to an unaffiliated third party bind itself to the Irrevocable

Proxy.

The Irrevocable Proxy was executed on February 5, 1997 by the then-owner of all

100 shares of issued and outstanding stock of Danco GP. It granted three individuals,

including Daniel, the power to vote the Proxy Shares (defined below). On January 1, 1999,

as part of an internal restructuring in which the Partnership was created and acquired 75%

of the Proxy Shares, the Partnership executed an Agreement To Be Bound By Irrevocable

Proxy and Power Of Attorney, binding itself to the Irrevocable Proxy.2

The Partnership dissolved on February 28, 2021, and is now in the process of

winding up. As its principal asset, it owns 75% of the issued and outstanding stock of

Danco GP (the “Majority Shares”). Appellee currently owns 88% of the Partnership and

1 MedApproach Holdings, Inc., referred to herein as “Holdings” is also named as a defendant. Daniel owns 100% of Holdings. 2 App. to Opening Br. at A370 (Agreement To Be Bound By Irrevocable Proxy and Power of Attorney).

2 desires to purchase the Majority Shares in the winding up process. But for the Irrevocable

Proxy, the owner of the Majority Shares would control both Danco GP and the entity

managed by Danco GP, Danco LP (defined below).

Daniel appeals the Court of Chancery’s judgment that the Irrevocable Proxy does

not run with the Majority Shares.3 He argues that the Court of Chancery committed the

following legal errors: (1) first, rather than interpret and apply the plain language of the

Irrevocable Proxy as written, the Court of Chancery erred in relying on the Restatement

(Third) of Agency, which was not adopted until nearly a decade after the parties entered

into the Irrevocable Proxy, (2) second, it read additional language into the Irrevocable

Proxy in order to support its finding that the broad “catch-all” language that the parties

included to prevent termination of the Irrevocable Proxy did not encompass a sale of the

shares, and (3) third, it did not give effect to all of the terms of the Irrevocable Proxy and

it improperly limited the assignment clause of the Irrevocable Proxy so as not to bind

assigns of the stockholder.

For the reasons set forth below, we AFFIRM the judgment of the Court of

Chancery.

3 Daniel does not challenge the Court of Chancery’s conclusion that the Addendum does not obligate the Partnership to demand that the buyer in a sale to an unaffiliated third party bind itself to the Irrevocable Proxy.

3 I. FACTUAL AND PROCEDURAL BACKGROUND4

A. The Founding of the Project

Population Council, Inc. (“Popco”) is an international not-for-profit corporation

focused on family planning. In 1994, a French pharmaceutical company granted Popco a

license to manufacture, market, and distribute the oral abortion drug RU-486, more

commonly known as mifepristone. Once granted the license, Popco began a search for an

investor to manufacture and distribute the drug for domestic and international use (the

“Project”). In what would turn out to be an unfortunate choice, Popco selected Joseph D.

Pike (“Pike”), who it had previously worked with on similar ventures, to undertake the

Project.

Pike formed a complex entity structure to consummate the venture, placing himself

at the helm. He formed Danco Laboratories, Inc., a Cayman Islands company (“Danco

Labs”) as the main operating entity. Danco Labs subsequently domesticated into a

Delaware limited liability company and is now known as Danco Laboratories, LLC.

Through an affiliate, Popco granted an exclusive sublicense to Danco Labs to implement

the Project in the United States.5 Ultimately, the outcome of this litigation will determine

the control arrangement of Danco Labs.

Pike then formed Neogen Investors L.P., a California limited partnership. Neogen

Investors L.P. is now known as Danco Investors Group, L.P. (“Danco LP”). Danco LP

4 Unless otherwise noted, facts are taken from the Court of Chancery’s memorandum opinion. See Hawkins v. Daniel (Chancery Opinion), 273 A.3d 792 (Del. Ch. 2022). 5 App. to Opening Br. at A132 (Offering Memorandum at 1).

4 owns 100% of Danco Labs and was formed as a holding company to raise equity financing

for the Project. Pike’s goal was to solicit investors to invest in Danco Labs by purchasing

limited partnership interests in Danco LP.

Lastly, Pike formed N.D. Management, Inc., a Cayman Islands company (“Danco

GP”) as Danco LP’s general partner. Danco GP has since domesticated into a Delaware

corporation. Initially, Pike owned 100% of Danco GP, which consists of 100 shares of

issued and outstanding stock. Because Danco GP controlled Danco LP as its general

partner, and Danco LP owns 100% of Danco Labs, Pike effectively controlled Danco Labs

through his 100% ownership of Danco GP. The same remains true today: whoever

controls Danco GP controls Danco Labs and the Project.

Pike then began raising money for the Project by selling limited partnership interests

in Danco LP. From about November 1995 to February 1997, Pike raised approximately

$13.35 million.6 One of Pike’s primary investors was appellant Daniel. Daniel invested

in Danco LP through his newly formed entity MedApproach L.P., a Tennessee limited

partnership (“Old MedApproach”), which he caused to purchase limited partnership

interests in Danco LP. At the time, Daniel owned Old MedApproach through its general

partner, Bio-Pharm Investments, Inc., a Tennessee corporation. Bio-Pharm Investments,

Inc. has since become defendant below-appellant Med Approach Holdings, Inc., a

Delaware corporation (“Holdings”). Daniel owns 100% of Holdings. In 1999, Old

6 Id. at A135 (Offering Memorandum at 4).

5 MedApproach was restructured and divided into three separate entities, one of which is the

Partnership.

Around this time, Daniel was introduced to Mrs. Hawkins’ husband, Gregory

Hawkins (“Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Webster v. Upton
91 U.S. 65 (Supreme Court, 1876)
Barnhart v. Thomas
540 U.S. 20 (Supreme Court, 2003)
Haft v. Haft
671 A.2d 413 (Court of Chancery of Delaware, 1995)
Lorillard Tobacco Co. v. American Legacy Foundation
903 A.2d 728 (Supreme Court of Delaware, 2006)
Interim Healthcare, Inc. v. Spherion Corp.
884 A.2d 513 (Superior Court of Delaware, 2005)
Kuhn Construction, Inc. v. Diamond State Port Corp.
990 A.2d 393 (Supreme Court of Delaware, 2010)
Moran v. Household International, Inc.
500 A.2d 1346 (Supreme Court of Delaware, 1985)
Crown Emak Partners, LLC v. Kurz
992 A.2d 377 (Supreme Court of Delaware, 2010)
In Re Lear Corp. Shareholder Litigation
926 A.2d 94 (Court of Chancery of Delaware, 2007)
Unitrin, Inc. v. American General Corp.
651 A.2d 1361 (Supreme Court of Delaware, 1995)
Samson v. Smith
560 A.2d 1024 (Supreme Court of Delaware, 1989)
Commonwealth Associates v. Providence Health Care, Inc.
641 A.2d 155 (Court of Chancery of Delaware, 1993)
Eliason v. Englehart
733 A.2d 944 (Supreme Court of Delaware, 1999)
Sonitrol Holding Co. v. Marceau Investissements
607 A.2d 1177 (Supreme Court of Delaware, 1992)
Kurz v. Holbrook
989 A.2d 140 (Court of Chancery of Delaware, 2010)
Schreiber v. Carney
447 A.2d 17 (Court of Chancery of Delaware, 1982)
Concord Real Estate Cdo 2006-1, Ltd. v. Bank of America N.A.
996 A.2d 324 (Court of Chancery of Delaware, 2010)
Giuricich v. Emtrol Corp.
449 A.2d 232 (Supreme Court of Delaware, 1982)
E. I. Du Pont De Nemours & Co. v. Green
411 A.2d 953 (Supreme Court of Delaware, 1980)
Rubick v. Security Instrument Corp.
766 A.2d 15 (Supreme Court of Delaware, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Daniel v. Hawkins, Counsel Stack Legal Research, https://law.counselstack.com/opinion/daniel-v-hawkins-del-2023.